Seven-valent pneumococcal conjugate vaccines for developing countries (Q37559638)

21 August 2017

1 reference

title

Seven-valent pneumococcal conjugate vaccines for developing countries (English)

1 reference

21 August 2017

Stephen Obaro

1

1 reference

21 August 2017

publication date

1 August 2009

1 reference

Expert Review of Vaccines

21 August 2017

published in

1 reference

21 August 2017

volume

8

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

1051-1061

1 reference

The preventable burden of pneumococcal disease in the developing world

21 August 2017

cites work

1 reference

Strategies for the control of pneumococcal diseases

21 January 2018

1 reference

Bacteremia among children admitted to a rural hospital in Kenya

21 January 2018

1 reference

Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study

21 January 2018

1 reference

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Efficacy of pneumococcal conjugate vaccines in large scale field trials

21 January 2018

1 reference

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

The introduction of new vaccines into developing countries.

21 January 2018

1 reference

Bacteraemia in severely malnourished children in an HIV-endemic setting

21 January 2018

1 reference

Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia

21 January 2018

1 reference

Invasive pneumococcal infections among hospitalized children in Bamako, Mali

21 January 2018

1 reference

Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda

21 January 2018

1 reference

Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study

21 January 2018

1 reference

Community-acquired bacteremia among hospitalized children in rural central Africa

21 January 2018

1 reference

Bacterial isolates in the sick young infant in Ile-Ife, Nigeria

21 January 2018

1 reference

Invasive pneumococcal disease in children<5 years of age in rural Mozambique.

21 January 2018

1 reference

Acute bacterial meningitis at the 'Complexe Pédiatrique' of Bangui, Central African Republic

21 January 2018

1 reference

Epidemiology of invasive pneumococcal disease in Kumasi, Ghana

21 January 2018

1 reference

Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia

21 January 2018

1 reference

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

21 January 2018

1 reference

World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines

21 January 2018

1 reference

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children

21 January 2018

1 reference

Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution.

21 January 2018

1 reference

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

21 January 2018

1 reference

Streptococcus pneumoniae serotype 19A in children, South Korea

21 January 2018

1 reference

The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease

21 January 2018

1 reference

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

21 January 2018

1 reference

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine

21 January 2018

1 reference

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine

21 January 2018

1 reference

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

21 January 2018

1 reference

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects

21 January 2018

1 reference

Control of pneumococcal disease in the United Kingdom--the start of a new era.

21 January 2018

1 reference

Current issues regarding the use of pneumococcal conjugate and polysaccharide vaccines in Australian children

21 January 2018

1 reference

The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study

21 January 2018

1 reference

Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.66

1 reference

21 August 2017

1 reference